Description
Nilotinib, marketed under the brand name Tasigna, It is an prescription medication that has been approved nilotinib (Tasigna) for medical use on October 29, 2007. The European Medicines Agency (EMA) approved it in September 2009, the MHRA in November 2007, and the TGA in January 2008.
What is Tasigna (Nilotinib) ?
Indications and usage: Newly diagnosed Ph+ CML-CP 06/2010 Dosage and administration: Recommended Dosing, Dose Adjustments or Modifications 06/2010 Warnings and precautions: Myelosuppression, Sudden Deaths, Elevated Serum Lipase, Total Gastrectomy
Treatment of newly diagnosed adult patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase. The study is ongoing and further data will be required to determine long-term outcome.
Treatment of chronic phase (CP) and accelerated phase (AP) Ph+ CML in adult patients resistant to or intolerant to prior therapy that included imatinib. Clinical benefit, such as improvement in disease-related symptoms or increased survival, has not been demonstrated.
How to order approved “Tasigna (Nilotinib) for Capsules” Medicine?
Tasigna (Nilotinib) Capsules is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing Tasigna and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
